General Information of the Compound
Compound ID
CP0689377
Compound Name
SPEBRUTINIB
    Show/Hide
Synonyms
1202757-89-8
AK198940
AVL 292
AVL-292
AVL292
Btk inhibitor CC-292
CC-292
CC-292 (AVL-292)
CHEMBL3301625
DRU6NG543J
EX-A255
GTPL7837
N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide
N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide
N-[3-[[5-fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide
SCHEMBL626216
Spebrutinib (USAN/INN)
Spebrutinib [USAN:INN]
UNII-DRU6NG543J
cc-292
spebrutinib
    Show/Hide
Structure
Formula
C22H22FN5O3
Molecular Weight
423.448
Canonical SMILES
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
    Show/Hide
InChI
InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28)
    Show/Hide
InChIKey
KXBDTLQSDKGAEB-UHFFFAOYSA-N
CAS
1202757-89-8
Physicochemical Property
logP
4.2526
Rotatable Bonds
10
Heavy Atom Count
31
Polar Areas
97.4
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
7
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 59174488
SID: 163515657
ChEMBL ID
CHEMBL3301625
DrugBank ID
DB11764
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01669, Cytoplasmic tyrosine-protein kinase BMX
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 2665 nM
   TI
   LI
   LO
   TS
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 442 nM
   TI
   LI
   LO
   TS
Protein ID: PT01308, Tyrosine-protein kinase BTK
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  5
1
IC50 = 0.6 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.72 nM
   TI
   LI
   LO
   TS
3
IC50 = 2.12 nM
   TI
   LI
   LO
   TS
4
IC50 = 9 nM
   TI
   LI
   LO
   TS
5
Ki = 20.7 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.7 nM
2 IC50 = 1 nM
3 IC50 = 4.61 nM
Protein ID: PT00892, Tyrosine-protein kinase JAK3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  3
1
IC50 = 22.5 nM
   TI
   LI
   LO
   TS
2
IC50 = 66.5 nM
   TI
   LI
   LO
   TS
3
IC50 = 1753 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000001 Jurkat Homo sapiens (Human)  1
1
IC50 = 6700 nM
   TI
   LI
   LO
   TS
CL000003 Ramos Homo sapiens (Human)  1
1
IC50 = 20900 nM
   TI
   LI
   LO
   TS
CL000007 HT-29 Homo sapiens (Human)  1
1
IC50 = 18900 nM
   TI
   LI
   LO
   TS
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 33500 nM
   TI
   LI
   LO
   TS
CL000083 MCF-7 Homo sapiens (Human)  1
1
IC50 = 29000 nM
   TI
   LI
   LO
   TS
CL000111 MDA-MB-231 Homo sapiens (Human)  1
1
IC50 > 40000 nM
   TI
   LI
   LO
   TS
CL000174 Raji Homo sapiens (Human)  1
1
IC50 = 29400 nM
   TI
   LI
   LO
   TS
CL000243 MCF-10A Homo sapiens (Human)  1
1
IC50 = 4360 nM
   TI
   LI
   LO
   TS
CL000244 786-O Homo sapiens (Human)  1
1
IC50 = 14900 nM
   TI
   LI
   LO
   TS
CL000320 NCI-H3122 Homo sapiens (Human)  1
1
IC50 = 32500 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( CC-292 )
Drug Name CC-292
Company Celgene
Indication
Chronic lymphocytic leukaemia
Phase 2
Target(s)
Tyrosine-protein kinase BTK (ATK)
Modulator